Focus of new FDA division is AIDS, opportunistic infections.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D006801:Humans; D009894:Opportunistic Infections / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration